We are live on ! Find out more
VTAK icon

Catheter Precision

17 hedge funds and large institutions have $292K invested in Catheter Precision in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more capital invested

Capital invested by funds: $257K → $292K (+$35.7K)

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

6% more funds holding

Funds holding: 1617 (+1)

0% more ownership

Funds ownership: 0%0% (+0%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
Reduced
1
Closed
8
Calls
Puts
Net Calls
Net Calls Change

VTAK Hedge Fund Activity: Q3 2022 in Review

17 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q3 2022, worth a combined $292K — up 14% from $257K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new VTAK positions and 8 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Spire Wealth Management, opening a new position worth an estimated $207K. The largest seller was Vanguard Group, cutting an estimated $24.7K.

  • 17 institutional investors held Catheter Precision (VTAK) as of Q3 2022, up from 16 in Q2 2022.
  • Funds reported $292K of Catheter Precision stock for Q3 2022, up 14% quarter-over-quarter.
  • 9 funds opened new Catheter Precision positions in Q3 2022 and 8 closed out, a net change of +1 holder.
  • The largest Catheter Precision buyer in Q3 2022 was Spire Wealth Management, an estimated $207K added.
  • The largest Catheter Precision seller in Q3 2022 was Vanguard Group, an estimated $24.7K sold.

Based on aggregated 13F filings for Q3 2022.